tak 779 has been researched along with ovalbumin in 1 studies
Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
---|---|---|---|---|---|
118 | 1 | 35 | 19,565 | 63 | 5,664 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamada, K; Ito, T; Kai, Y; Kimura, H; Nakajima, Y; Nomi, T; Sho, M; Suzaki, Y | 1 |
1 other study(ies) available for tak 779 and ovalbumin
Article | Year |
---|---|
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation.
Topics: Amides; Animals; Anti-Asthmatic Agents; Asthma; Disease Models, Animal; Female; Immunization; Mice; Mice, Inbred BALB C; Ovalbumin; Quaternary Ammonium Compounds; Receptors, CCR; Receptors, CCR3; Receptors, CCR5; Receptors, CXCR3 | 2008 |